Lisbon, Portugal

Arsenio Fialho

This inventor holds 22 USPTO granted patents and 1 published patent application, primarily in Cupredoxin Research. Top assignees: University of Illinois, Other. Active years: 2007-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Arsenio Fialho. Retrieved from https://idiyas.com/inventor/arsenio-fialho

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 22 

% Patents Active = 77.3

Average Co-Inventor Count = 5.2

ph-index = 6

Forward Citations = 158(Granted Patents)


Company Filing History:


Years Active: 2007-2021

Loading Chart...
Areas of Expertise:
Cupredoxin
HIV Treatment
Blood-Brain Barrier
Transport Agents
Ephrin Signaling
Malaria Treatment
Cytochrome C
Brain Cancer
22 patents (USPTO):Explore Patents

Title: Arsenio Fialho: Innovator in Cupredoxin Research

Introduction

Arsenio Fialho, a distinguished inventor based in Lisbon, Portugal, has made significant contributions to the field of biochemistry and molecular biology. With a remarkable portfolio of 22 patents, his innovative work primarily focuses on the therapeutic applications of cupredoxins in treating various medical conditions, including cancer and HIV.

Latest Patents

Fialho's recent groundbreaking patents include compositions and methods for treating conditions related to ephrin signaling with cupredoxins. This invention revolves around the use of cupredoxins, such as azurin, rusticyanin, and plastocyanin, which demonstrate potential in disrupting the ephrin signaling system within mammalian cells. Particularly, these compositions are aimed at treating cancer in mammals.

Another notable patent involves the development of compositions for treating HIV infection using cupredoxin and cytochrome c. This invention highlights the effectiveness of azurin and cytochrome c in inhibiting viral infections, specifically targeting the Human Immunodeficiency Virus (HIV). Additionally, it explores variants and derivatives of these compounds that maintain the capacity to inhibit viral infections, thereby enhancing research methods relevant to studying viral and bacterial infections in mammalian cells.

Career Highlights

Arsenio Fialho has honed his expertise while contributing to significant research at reputable institutions, notably the University of Illinois. His work has paved the way for potential breakthroughs in medical treatments, showcasing his deep commitment to advancing scientific knowledge and therapeutic possibilities.

Collaborations

Fialho has collaborated with notable individuals in the scientific community, including Ananda M Chakrabarty and Tapas Das Gupta. These partnerships have fostered an environment of innovation and shared knowledge, further driving the progress of research and development in biochemistry.

Conclusion

Arsenio Fialho stands out as an influential inventor, pushing the boundaries of scientific understanding through his work with cupredoxins. His contributions not only showcase his dedication to innovation in therapeutic treatments but also reflect the collaborative spirit that characterizes successful scientific endeavors. With his growing patent portfolio, Fialho continues to make a lasting impact on the fields of health and medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…